CAROTENUTO, ALFONSO
 Distribuzione geografica
Continente #
NA - Nord America 2.635
EU - Europa 1.641
AS - Asia 488
AF - Africa 55
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 3
Totale 4.830
Nazione #
US - Stati Uniti d'America 2.558
IT - Italia 679
CN - Cina 403
IE - Irlanda 223
NL - Olanda 177
FI - Finlandia 161
UA - Ucraina 145
DE - Germania 95
CA - Canada 77
SE - Svezia 73
CI - Costa d'Avorio 54
GB - Regno Unito 54
IN - India 40
VN - Vietnam 17
FR - Francia 14
TR - Turchia 9
SG - Singapore 7
BG - Bulgaria 6
BE - Belgio 5
IR - Iran 5
JP - Giappone 4
ES - Italia 3
EU - Europa 3
NZ - Nuova Zelanda 3
OM - Oman 3
AU - Australia 2
RO - Romania 2
AR - Argentina 1
BR - Brasile 1
CL - Cile 1
CZ - Repubblica Ceca 1
EE - Estonia 1
GR - Grecia 1
KE - Kenya 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 4.830
Città #
Chandler 585
Amsterdam 174
Millbury 174
Princeton 169
Jacksonville 156
Ashburn 151
Naples 146
Nanjing 132
Boston 122
Napoli 115
Beijing 85
Ottawa 66
Wilmington 66
Des Moines 62
Woodbridge 55
Ann Arbor 46
Nanchang 38
Shenyang 30
Hebei 24
Falls Church 21
Seattle 20
Houston 19
Rome 19
Jiaxing 18
Tianjin 18
Boardman 16
Kronberg 16
Augusta 15
Norwalk 15
Dong Ket 14
Lawrence 14
Bologna 13
Changsha 13
Florence 12
Hangzhou 12
Milan 12
Washington 12
Dearborn 10
Toronto 9
Arce 8
Pune 8
Orange 7
Frankfurt am Main 6
Indiana 6
Quarto 6
Salerno 6
Dublin 5
Fairfield 5
Genoa 5
Guangzhou 5
Kunming 5
Redwood City 5
Amorosi 4
Catania 4
Ixelles-Elsene 4
Ningbo 4
Paris 4
Portici 4
Santa Maria Capua Vetere 4
Sarno 4
Viterbo 4
Arzano 3
Hanoi 3
Ischia 3
Jinhua 3
Leawood 3
Mountain View 3
Mugnano di Napoli 3
New York 3
Newark 3
Pinole 3
Piombino 3
Potenza 3
San Giuliano Terme 3
San Mateo 3
Serino 3
Singapore 3
Sofia 3
Tappahannock 3
Albenga 2
Ardabil 2
Aversa 2
Bacoli 2
Bengaluru 2
Cachan 2
Campagnola Cremasca 2
Caserta 2
Chieti 2
Cisterna di Latina 2
Coquitlam 2
Coventry 2
Crevalcore 2
Cusano Milanino 2
Empoli 2
Formia 2
Lanzhou 2
London 2
Lucknow 2
Marano di Napoli 2
Marigliano 2
Totale 2.903
Nome #
Antimicrobial peptide Temporin-L complexed with anionic cyclodextrins results in a potent and safe agent against sessile bacteria 78
Functional Selectivity Revealed by N-Methylation Scanning of Human Urotensin II and Related Peptides 71
1H and 15N sequential assignment and secondary structure of the monomeric N67D mutant of bovine seminal ribonuclease 64
Screening Platform toward New Anti-HIV Aptamers Set on Molecular Docking and Fluorescence Quenching Techniques 64
Alanine scanning analysis and structure-function relationships of the frog-skin antimicrobial peptide temporin-1Ta 59
Molecular Modeling of the Urotensin-UT Receptor Complex 57
Unraveling the active conformation of urotensin II 57
" Molecular Modelingof the Urotensin-II receptor Complex" 57
Urokinase receptor derived peptides as potent inhibitors of the formyl peptide receptor type 1-triggered cell migration 57
Unraveling the active conformation of urotensin II 52
Development of Antiviral Fusion Inhibitors: Short Modified Peptides Derived from the Transmembrane Glycoprotein of Feline Immunodeficiency Virus 51
A novel route to synthesize Freidinger lactams by microwave irradiation 51
In vitro evaluation of tumor targeting ability of a parenteral enoxaparin-coated self-emulsifying drug delivery system 49
Exploring the N-Terminal Region of C-X-C Motif Chemokine 12 (CXCL12): Identification of Plasma-Stable Cyclic Peptides As Novel, Potent C-X-C Chemokine Receptor Type 4 (CXCR4) Antagonists 47
A nutraceutical formulation based on Annurca apple polyphenolic extract is effective on intestinal cholesterol absorption: A randomised, placebo-controlled, crossover study 47
Urotensin-II Receptor Antagonists 46
Glycine-replaced derivatives of [Pro3,DLeu9]TL, a temporin L analogue: Evaluation of antimicrobial, cytotoxic and hemolytic activities 46
Morphicetin analogues containing a new β-turn thiazolidine mimetic 45
Native PAGE to study the interaction between the oncosuppressor p53 and its protein ligands 44
An investigation into the origin of the biased agonism associated with the urotensin II receptor activation 43
Development and Identification of a Novel Anti-HIV-1 Peptide Derived by Modification of the N-Terminal Domain of HIV-1 Integrase 43
Disulfide bond replacement with 1,4‐ and 1,5‐disubstituted [1,2,3]‐triazole on C‐X‐C chemokine receptor type 4 (CXCR4) peptide ligands: small changes that make big differences 43
Synthesis of a Dicarba-Analog of Octreotide Keeping the Type II Beta-Turn of the Pharmacophore in Water Solution 42
12-Keto-Porrigenin and the Unique 2,3-Seco-Porrigenin, New Antiproliferative Sapogenins isolated from Allium porrum. 42
Structure-function Relationships and Conformational Properties of alpha-MSH(6-13) Analogues with Candidacidal Activity 41
Design, Synthesis, and Evaluation of Gluten Peptide Analogs as Selective 401 Inhibitors of Human TG2 41
Discovery of New Potent Ligands at Human Urotensin-II Receptor 41
D-Amino Acids Containing Temporin L Analogues 41
Nondenaturing polyacrylamide gel electrophoresis to study the dissociation of the p53·MDM2/X complex by potentially anticancer compounds 41
Urotensin-II Receptor Ligands. From Agonist to Antagonist Activity 40
Solution structure of monomeric bovine seminal ribonuclease 40
"3D Structural analysis of Urotensin-II analogues in membrane mimetic environment" 40
Structure-Activity Relationships and Biological Characterization of a Novel, Potent, and Serum Stable C-X-C Chemokine Receptor Type 4 (CXCR4) Antagonist 40
Ligand-Based NMR Study of C-X-C Chemokine Receptor Type 4 (CXCR4)-Ligand Interactions on Living Cancer Cells 40
Conformation-Activity Relationship of Designed Glycopeptides as Synthetic Probes for the Detection of Autoantibodies, Biomarkers of Multiple Sclerosis 39
Design and Synthesis of Spirotryprostatin-inspired Diketopiperazine Systemsfrom Prolyl Spirooxoindolethiazolidine Derivatives 39
An ancestral host defence peptide within human β-defensin 3 recapitulates the antibacterial and antiviral activity of the full-length molecule 39
The flavonoids of Allium Neapolitanum. 38
A New, Potent Urotensin II Receptor Peptide Agonist Containing a Pen Residue at the Disulfide Bridge 38
Retro-Inverso Analogue of the Antiviral Octapeptide C8 Inhibits Feline Immunodeficiency Virus in Serum 38
Urotensin-II Receptor Peptide Agonists 38
SAR study and conformational analysis of a series of novel peptide G protein-coupled receptor kinase 2 inhibitors 37
Identification of the Spiro(oxindole-3,3’-thiazolidine)-Based Derivatives as Potential p53 Activity Modulators 37
Novel α-MSH peptide analogues with broad spectrum antimicrobial activity. 37
Design, synthesis, and conformational analysis of Melanotropin analogues of MTII and SHU9119. 37
Recognition Properties of V3-Specific Antibodies to V3 Loop Peptides Derived from HIV-1 Gp120 Presented in Multiple Conformations 36
Structural Studies on Hgr3 Orphan Receptor Ligand Prolactin-Releasing Peptide. 36
A proteomic approach to characterize a native antigen involved in autoantibody response in multiple sclerosis by a structure-based designed glycopeptide 36
THE FLAVONOIDS OF ALLIUM URSINUM 35
An N-Glucosylated Peptide Detecting Disease-Specific Autoantibodies, Biomarkers of Multiple Sclerosis 35
Design, Synthesis, and Conformational Analysis of Melanotropin Analogues of MTII and SHU9119 35
null 35
Design, Synthesis, and Cytotoxic Evaluation of AcylDerivatives of 3-Aminonaphtho[2,3-b]thiophene-4,9-dione, a Quinone-Based System 34
B-Hairpin Glycopeptides as Mimetic Autoantigens in Multiple Sclerosis 34
Antiproliferative sesterterpenes from the Caribbean sponge Cacospongia cf. linteiformis. 34
Discovery of Novel Potent and Selective Agonists at the Melanocortin-3 Receptor 34
3D structure of monomeric bovine seminal ribonuclease by heteronuclear NMR 33
New Anticancer Agents Mimicking Protein Recognition Motifs. 33
Design and synthesis of the small libraries of peptidomimetics based on thiazolidine moiety 32
New insight into the binding mode of cyclic melanocortin ligands at the MC4 receptor 32
Alanine scanning analysis and structure-function relationships of the frog-skin antimicrobial peptide temporin-1Ta. 32
Structure-Activity Study of the Peptides P5U and Urantide by the Development of Analogues Containing Uncoded Amino Acids at Position9 32
Breast tumor cell invasion and pro-invasive activity of cancer-associated fibroblasts co-targeted by novel urokinase-derived decapeptides 32
NMR analysis of synthetic peptides agonist to PTPRJ, a receptor-type protein tyrosine phosphatase with tumor suppressor activity. 31
"Urotensin-II (U-II) analogues containing modifications at disulfide bridge Synthesis, biological and conformational studies" 31
Amino acid derivatives as new zinc binding groups for the design of selective matrix metalloproteinase inhibitors 31
Apoptosis Therapy in Cancer: The First Single-molecule Co-activating p53 and the Translocator Protein in Glioblastoma 31
Host Defense Peptide-derived Privileged Scaffolds for Anti-infective Drug Discovery 31
New insight into the binding mode of peptide ligands at Urotensin-II receptor: structure-activity relationships study on P5U and urantide 30
A De Novo Designed Library of Linear Helical Peptides: An Exploratory Tool in the Discovery of Protein-Protein Interaction Modulators 30
NEW INSIGHT INTO THE BINDING MODE OF CYCLIC MELANOCORTIN LIGANDS AT THE MC4 RECEPTOR 30
HOPPI-NMR: Hot-Peptide-Based Screening Assay for Inhibitors of Protein-Protein Interactions by NMR 30
A novel β-hairpin peptide derived from the ARC repressor selectively interacts with the major groove of B-DNA 30
First-in-Class Cyclic Temporin L Analogue: Design, Synthesis, and Antimicrobial Assessment 30
The Outcomes of Decorated Prolines in the Discovery of Antimicrobial Peptides from Temporin-L 29
Urantide Conformation and Interaction with the Urotensin-II Receptor 28
Development of Macrocyclic Peptidomimetics Containing Constrained α,α-Dialkylated Amino Acids with Potent and Selective Activity at Human Melanocortin Receptors 28
SOLUTION STRUCTURE OF MONOMERIC BOVINE SEMINAL RIBONUCLEASE 27
Structures and micelle locations of the nonlipidated and lipidated C-terminal membrane anchor of 2’,3’-cyclic nucleotide-3’-phosphodiesterase 27
Porrigenins A and B, novel cytotoxic and antiproliferative sapogenins isolated from Allium porrum 27
beta-HAIRPIN GLYCOPEPTIDES AS MIMETIC AUTOANTIGENS IN MULTIPLE SCLEROSIS 27
Design, synthesis and efficacy of novel G protein-coupled receptor kinase 2 inhibitors 27
Structure-Activity Relationship Studies, SPR Affinity Characterization, and Conformational Analysis of Peptides That Mimic the HNK-1 Carbohydrate Epitope 27
Spiro[(dihydropyrazin-2,5-dione)-6,3’-(2’,3’-dihydrothieno[2,3-b]naphtho-4’,9’-dione)]-Based Cytotoxic Agents: Structure-Activity Relationship Studies on the Substituent at N4-Position of the Diketopiperazine Domain 26
Stereostructures of new bioactive sesterterpenes isolated from the Caribbean sponge Cacospongia cf. linteiformis 26
Sequence-Specific 1H, 13C and 15N Assignment and Secondary Structure of the Apo EH2 Domain of Mouse Eps15 25
Structure and absolute stereochemistry of the new cyclolinteinol and cyclolinteinol acetate, macrophage activation modulators 25
Combinatorial Approach in the Synthesis of a Small Library of β-Turn Structures Based on Thiazolidine Moiety 25
Design, synthesis, and evaluation of gluten peptide analogs as selective inhibitors of human TG2 25
Characterization of a selective CaMKII peptide inhibitor 25
Development of Cyclic Peptide Inhibitors of GRK2 25
Role of Lipoylation of the Immunodominant Epitope of Pyruvate Dehydrogenase Complex: Toward a Peptide-Based Diagnostic Assay for Primary Biliary Cirrhosis 25
Structure- and conformation-activity studies of nociceptin/orphanin FQ receptor dimeric ligands 25
Constrained Peptides with Fine-Tuned Flexibility Inhibit NF-Y Transcription Factor Assembly 24
The EH1 Domain of Eps15 Is Structurally Classified as a Member of the S100 Subclass of EF-Hand-Containing Proteins 24
Monitoring the effect of antagonist on P53-MDM2 interaction with NMR spectroscopy. Recent results 24
Novel cyclic biphalin analogue with improved antinociceptive properties. 24
SAR Study and Conformational Analysis of a Series of Novel GRK2 Peptide inhibitors 24
DOTA-Derivatives of Octreotide Dicarba-Analogs with High Affinity for Somatostatin sst2,5 Receptors 24
Investigation on side-product formation during the synthesis of a lactoferrin-derived lactam-bridged cyclic peptide 24
Totale 3.689
Categoria #
all - tutte 18.951
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.951


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201936 0 0 0 0 0 0 0 0 7 6 6 17
2019/2020623 232 13 37 24 64 7 20 12 6 60 78 70
2020/2021572 35 37 48 35 61 138 36 14 47 22 75 24
2021/20221.035 25 7 12 26 19 22 16 27 234 81 121 445
2022/20231.363 198 102 54 127 153 149 9 121 193 169 63 25
2023/2024744 55 140 177 57 67 93 16 127 12 0 0 0
Totale 5.155